UnitedHealth Group (NYSE:UNH) Trading Down 2.8% – Time to Sell?

UnitedHealth Group Incorporated (NYSE:UNH)’s stock price traded down 2.8% during trading on Thursday . The stock traded as low as $276.29 and last traded at $277.2880. 10,347,432 shares traded hands during mid-day trading, an increase of 4% from the average session volume of 9,916,084 shares. The stock had previously closed at $285.25.

Key Stories Impacting UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: U.S. Senator Markwayne Mullin reported buying $50k–$100k of UNH shares on Feb. 25, a high-profile insider purchase that can be read as a modest vote of confidence. Trump Ally, New DHS Leader Nominee Markwayne Mullin Makes New Stock Trades: Here’s What He Bought And Sold
• Positive Sentiment: UNH showed intraday resilience in recent sessions, advancing while the broader market dipped, suggesting relative strength versus peers on some trading days. UnitedHealth Group (UNH) Advances While Market Declines: Some Information for Investors
• Positive Sentiment: Weakness at Centene (a large peer) over ACA exposure may reallocate investor attention toward more diversified insurers like UNH, a potential relative benefit if concerns remain concentrated at competitors. Centene Is the Worst S&P 500 Stock Today. What’s Ailing the Health Insurer.
• Neutral Sentiment: Management presented at Barclays’ Global Healthcare conference; the transcript provides detail on strategy and execution but contains no clear new guidance that would meaningfully move the stock alone. UnitedHealth Group Incorporated (UNH) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
• Neutral Sentiment: Recent analyst reports and stock forecasts are circulating but show a range of views — keep an eye on guidance and consensus revisions for a clearer directional signal. UnitedHealth Group Incorporated (UNH) Stock Forecasts
• Negative Sentiment: Several pieces highlight recent share-price weakness and negative total returns year-to-date and over the past year, raising valuation concerns that can pressure the stock. A Look At UnitedHealth Group’s Valuation After Recent Share Price Weakness
• Negative Sentiment: Sector headwinds — rising medical costs, nursing shortages and reimbursement pressures — remain a recurring theme in coverage and could weigh on margins and sentiment for HMO/insurer stocks. 4 HMO Stocks to Watch Despite Escalating Costs, Nursing Shortage
• Negative Sentiment: Some outlets flagged the Mullin purchase as “suspicious” (timing/filing questions), which could create short-term headlines and investor nervousness despite being a disclosed trade. U.S. senator Markwayne Mullin just made a super suspicious stock trade

Analyst Ratings Changes

Several analysts have recently weighed in on UNH shares. JPMorgan Chase & Co. dropped their price target on shares of UnitedHealth Group from $425.00 to $389.00 and set an “overweight” rating for the company in a research note on Monday, February 2nd. Piper Sandler reissued an “overweight” rating on shares of UnitedHealth Group in a research note on Tuesday, January 27th. Wells Fargo & Company lowered their price target on UnitedHealth Group from $400.00 to $370.00 and set an “overweight” rating for the company in a report on Friday, January 30th. Jefferies Financial Group reduced their price objective on shares of UnitedHealth Group from $418.00 to $340.00 and set a “buy” rating on the stock in a report on Wednesday, January 28th. Finally, Oppenheimer cut their price target on shares of UnitedHealth Group from $415.00 to $385.00 and set an “outperform” rating on the stock in a research note on Wednesday, January 28th. One equities research analyst has rated the stock with a Strong Buy rating, seventeen have issued a Buy rating, eight have assigned a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat.com, UnitedHealth Group currently has a consensus rating of “Moderate Buy” and an average price target of $372.13.

UnitedHealth Group Trading Down 2.8%

The business’s fifty day simple moving average is $305.51 and its two-hundred day simple moving average is $325.43. The company has a quick ratio of 0.79, a current ratio of 0.79 and a debt-to-equity ratio of 0.72. The company has a market cap of $251.69 billion, a price-to-earnings ratio of 21.02, a PEG ratio of 1.30 and a beta of 0.41.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, January 27th. The healthcare conglomerate reported $2.11 EPS for the quarter, beating analysts’ consensus estimates of $2.09 by $0.02. The firm had revenue of $113.73 billion for the quarter, compared to the consensus estimate of $113.38 billion. UnitedHealth Group had a net margin of 2.69% and a return on equity of 14.79%. The company’s revenue was up 12.3% on a year-over-year basis. During the same period last year, the firm posted $6.81 EPS. UnitedHealth Group has set its FY 2026 guidance at 17.750- EPS. On average, equities analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 17th. Shareholders of record on Monday, March 9th will be paid a $2.21 dividend. The ex-dividend date is Monday, March 9th. This represents a $8.84 dividend on an annualized basis and a yield of 3.2%. UnitedHealth Group’s payout ratio is currently 67.02%.

Institutional Trading of UnitedHealth Group

Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Guerra Advisors Inc purchased a new position in UnitedHealth Group in the third quarter valued at about $1,059,000. Berkshire Hathaway Inc acquired a new stake in shares of UnitedHealth Group in the 2nd quarter worth approximately $1,572,193,000. Carnegie Investment Counsel raised its holdings in UnitedHealth Group by 2.2% during the third quarter. Carnegie Investment Counsel now owns 105,621 shares of the healthcare conglomerate’s stock worth $36,471,000 after purchasing an additional 2,316 shares during the last quarter. EverSource Wealth Advisors LLC grew its holdings in UnitedHealth Group by 48.9% in the second quarter. EverSource Wealth Advisors LLC now owns 5,790 shares of the healthcare conglomerate’s stock valued at $1,806,000 after purchasing an additional 1,901 shares during the last quarter. Finally, Phoenix Financial Ltd. raised its stake in shares of UnitedHealth Group by 111.5% during the 3rd quarter. Phoenix Financial Ltd. now owns 41,986 shares of the healthcare conglomerate’s stock worth $14,282,000 after buying an additional 22,137 shares during the last quarter. 87.86% of the stock is owned by hedge funds and other institutional investors.

About UnitedHealth Group

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.